The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Oscar Health Inc shares valued at $11,551 were purchased by ALESSANDREA QUANE on Mar 10 ’25. At $16.50 per share, ALESSANDREA QUANE acquired 700 shares.
Also, ALESSANDREA QUANE purchased 5,101 shares, netting a total of over 84,181 in proceeds.
Before that, ALESSANDREA QUANE had added 20,000 shares to its account. In a trade valued at $325,654, the Officer bought Oscar Health Inc shares for $16.28 each.
As published in a research note from Wells Fargo on March 13, 2025, Oscar Health Inc [OSCR] has been rated down from an Overweight to an Equal weight and the price target has been revised to $16 from $20. Analysts at Jefferies started covering the stock with ‘”an Underperform”‘ outlook in a report released in early December. As of November 06, 2024, BofA Securities has decreased its “Neutral” rating to a “an Underperform” for OSCR. Earlier on October 07, 2024, UBS initiated its rating. Their recommendation was “a Neutral” for OSCR stock.
Analyzing OSCR Stock Performance
During the last five days, there has been a drop of approximately -2.83%. Over the course of the year, Oscar Health Inc shares have dropped approximately -0.52%. Shares of the company reached a 52-week high of $17.56 on 01/24/25 and a 52-week low of $12.43 on 02/13/25. A 50-day SMA is recorded $14.79, while a 200-day SMA reached $16.40.
Support And Resistance Levels for Oscar Health Inc (OSCR)
According to the 24-hour chart, there is a support level at 12.91, which, if violated, would cause prices to drop to 12.45. In the upper region, resistance lies at 13.63. The next price resistance is at 13.88. RSI (Relative Strength Index) is 44.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.17, which suggests the price will decrease in the coming days. Percent R is at 52.91%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
